GPR75 and obesity disorder: Activation of GPR75 and its ligand 20-HETE triggers pro-inflammatory and hypertensive signaling pathways, leading to diabetes, obesity, endothelial dysfunction, cell proliferation, hypertension, and cardiovascular diseases 15.